Identifies serum proteomic features in double-negative neuromyelitis optica spectrum disorder, suggesting candidate biomarkers for differentiation.
To define serum proteomic features and identify candidate biomarkers that distinguish double seronegative neuromyelitis optica spectrum disorder (DN-NMOSD) from AQP4-IgG positive neuromyelitis optica spectrum disorder (AQP4-IgG+ NMOSD) and relapsing–remitting multiple sclerosis (RRMS).
No takes yet. Share an insight, caveat, or question.
CANİK et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: